nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—UGT1A1—Etoposide—brain cancer	0.328	0.835	CbGbCtD
Naltrexone—ABCB1—Etoposide—brain cancer	0.065	0.166	CbGbCtD
Naltrexone—OPRM1—telencephalic ventricle—brain cancer	0.0164	0.155	CbGeAlD
Naltrexone—OPRD1—ganglion—brain cancer	0.015	0.141	CbGeAlD
Naltrexone—OPRM1—ganglion—brain cancer	0.0102	0.0962	CbGeAlD
Naltrexone—OPRD1—telencephalon—brain cancer	0.00578	0.0544	CbGeAlD
Naltrexone—OPRM1—brainstem—brain cancer	0.00444	0.0418	CbGeAlD
Naltrexone—OPRM1—telencephalon—brain cancer	0.00394	0.0371	CbGeAlD
Naltrexone—Buprenorphine—CYP2C9—brain cancer	0.00367	0.504	CrCbGaD
Naltrexone—Hydromorphone—CYP2C9—brain cancer	0.00362	0.496	CrCbGaD
Naltrexone—OPRD1—head—brain cancer	0.0036	0.0339	CbGeAlD
Naltrexone—OPRK1—head—brain cancer	0.00345	0.0325	CbGeAlD
Naltrexone—OPRD1—central nervous system—brain cancer	0.00328	0.0309	CbGeAlD
Naltrexone—UGT1A1—endocrine gland—brain cancer	0.00316	0.0298	CbGeAlD
Naltrexone—OPRK1—central nervous system—brain cancer	0.00315	0.0296	CbGeAlD
Naltrexone—OPRK1—cerebellum—brain cancer	0.00308	0.029	CbGeAlD
Naltrexone—OPRM1—midbrain—brain cancer	0.00283	0.0266	CbGeAlD
Naltrexone—OPRM1—spinal cord—brain cancer	0.00276	0.026	CbGeAlD
Naltrexone—OPRD1—brain—brain cancer	0.00261	0.0246	CbGeAlD
Naltrexone—OPRK1—brain—brain cancer	0.0025	0.0235	CbGeAlD
Naltrexone—OPRM1—endocrine gland—brain cancer	0.00248	0.0234	CbGeAlD
Naltrexone—OPRM1—head—brain cancer	0.00245	0.0231	CbGeAlD
Naltrexone—ABCB1—blood vessel—brain cancer	0.00234	0.0221	CbGeAlD
Naltrexone—OPRM1—central nervous system—brain cancer	0.00224	0.0211	CbGeAlD
Naltrexone—OPRM1—brain—brain cancer	0.00178	0.0167	CbGeAlD
Naltrexone—Cough—Procarbazine—brain cancer	0.0016	0.00324	CcSEcCtD
Naltrexone—Convulsion—Procarbazine—brain cancer	0.00159	0.00322	CcSEcCtD
Naltrexone—Hypertension—Procarbazine—brain cancer	0.00158	0.00321	CcSEcCtD
Naltrexone—Arthralgia—Procarbazine—brain cancer	0.00156	0.00316	CcSEcCtD
Naltrexone—Myalgia—Procarbazine—brain cancer	0.00156	0.00316	CcSEcCtD
Naltrexone—Anxiety—Procarbazine—brain cancer	0.00156	0.00315	CcSEcCtD
Naltrexone—Sweating increased—Temozolomide—brain cancer	0.00155	0.00314	CcSEcCtD
Naltrexone—Bronchitis—Temozolomide—brain cancer	0.00153	0.0031	CcSEcCtD
Naltrexone—Dry mouth—Procarbazine—brain cancer	0.00153	0.00309	CcSEcCtD
Naltrexone—Confusional state—Procarbazine—brain cancer	0.00151	0.00306	CcSEcCtD
Naltrexone—Vomiting—Lomustine—brain cancer	0.0015	0.00303	CcSEcCtD
Naltrexone—Oedema—Procarbazine—brain cancer	0.0015	0.00303	CcSEcCtD
Naltrexone—Infection—Procarbazine—brain cancer	0.00149	0.00301	CcSEcCtD
Naltrexone—Angiopathy—Hydroxyurea—brain cancer	0.00148	0.00299	CcSEcCtD
Naltrexone—Upper respiratory tract infection—Temozolomide—brain cancer	0.00148	0.00299	CcSEcCtD
Naltrexone—Pneumonia—Carmustine—brain cancer	0.00148	0.00299	CcSEcCtD
Naltrexone—Shock—Procarbazine—brain cancer	0.00147	0.00298	CcSEcCtD
Naltrexone—Depression—Carmustine—brain cancer	0.00146	0.00296	CcSEcCtD
Naltrexone—Chills—Hydroxyurea—brain cancer	0.00146	0.00296	CcSEcCtD
Naltrexone—Tachycardia—Procarbazine—brain cancer	0.00146	0.00296	CcSEcCtD
Naltrexone—Weight increased—Temozolomide—brain cancer	0.00145	0.00293	CcSEcCtD
Naltrexone—Hyperhidrosis—Procarbazine—brain cancer	0.00145	0.00293	CcSEcCtD
Naltrexone—Alopecia—Hydroxyurea—brain cancer	0.00144	0.00292	CcSEcCtD
Naltrexone—Weight decreased—Temozolomide—brain cancer	0.00144	0.00291	CcSEcCtD
Naltrexone—Urinary tract infection—Carmustine—brain cancer	0.00143	0.00289	CcSEcCtD
Naltrexone—Pneumonia—Temozolomide—brain cancer	0.00143	0.00289	CcSEcCtD
Naltrexone—Anorexia—Procarbazine—brain cancer	0.00143	0.00289	CcSEcCtD
Naltrexone—Infestation—Temozolomide—brain cancer	0.00142	0.00287	CcSEcCtD
Naltrexone—Infestation NOS—Temozolomide—brain cancer	0.00142	0.00287	CcSEcCtD
Naltrexone—Depression—Temozolomide—brain cancer	0.00141	0.00286	CcSEcCtD
Naltrexone—Nausea—Lomustine—brain cancer	0.0014	0.00283	CcSEcCtD
Naltrexone—Urinary tract infection—Temozolomide—brain cancer	0.00138	0.00279	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00136	0.00276	CcSEcCtD
Naltrexone—Insomnia—Procarbazine—brain cancer	0.00135	0.00274	CcSEcCtD
Naltrexone—Paraesthesia—Procarbazine—brain cancer	0.00134	0.00272	CcSEcCtD
Naltrexone—Hepatobiliary disease—Temozolomide—brain cancer	0.00134	0.00272	CcSEcCtD
Naltrexone—Sinusitis—Temozolomide—brain cancer	0.00133	0.00269	CcSEcCtD
Naltrexone—Somnolence—Procarbazine—brain cancer	0.00133	0.00269	CcSEcCtD
Naltrexone—Cramp muscle—Etoposide—brain cancer	0.00133	0.00269	CcSEcCtD
Naltrexone—Ill-defined disorder—Hydroxyurea—brain cancer	0.00132	0.00267	CcSEcCtD
Naltrexone—Hallucination—Carmustine—brain cancer	0.00131	0.00265	CcSEcCtD
Naltrexone—Decreased appetite—Procarbazine—brain cancer	0.0013	0.00263	CcSEcCtD
Naltrexone—Alanine aminotransferase increased—Etoposide—brain cancer	0.0013	0.00263	CcSEcCtD
Naltrexone—Connective tissue disorder—Carmustine—brain cancer	0.00129	0.00262	CcSEcCtD
Naltrexone—Fatigue—Procarbazine—brain cancer	0.00129	0.00261	CcSEcCtD
Naltrexone—Malaise—Hydroxyurea—brain cancer	0.00128	0.00259	CcSEcCtD
Naltrexone—Pain—Procarbazine—brain cancer	0.00128	0.00259	CcSEcCtD
Naltrexone—Constipation—Procarbazine—brain cancer	0.00128	0.00259	CcSEcCtD
Naltrexone—Hepatitis—Temozolomide—brain cancer	0.00127	0.00258	CcSEcCtD
Naltrexone—Hallucination—Temozolomide—brain cancer	0.00127	0.00257	CcSEcCtD
Naltrexone—Pharyngitis—Temozolomide—brain cancer	0.00126	0.00256	CcSEcCtD
Naltrexone—Connective tissue disorder—Temozolomide—brain cancer	0.00125	0.00253	CcSEcCtD
Naltrexone—Sweating increased—Etoposide—brain cancer	0.00124	0.00251	CcSEcCtD
Naltrexone—Feeling abnormal—Procarbazine—brain cancer	0.00123	0.0025	CcSEcCtD
Naltrexone—Eye disorder—Carmustine—brain cancer	0.00123	0.00249	CcSEcCtD
Naltrexone—Convulsion—Hydroxyurea—brain cancer	0.00123	0.00249	CcSEcCtD
Naltrexone—Gastrointestinal pain—Procarbazine—brain cancer	0.00122	0.00248	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.0012	0.00243	CcSEcCtD
Naltrexone—Discomfort—Hydroxyurea—brain cancer	0.00119	0.00242	CcSEcCtD
Naltrexone—Eye disorder—Temozolomide—brain cancer	0.00119	0.00241	CcSEcCtD
Naltrexone—Urticaria—Procarbazine—brain cancer	0.00119	0.00241	CcSEcCtD
Naltrexone—Tinnitus—Temozolomide—brain cancer	0.00119	0.0024	CcSEcCtD
Naltrexone—Abdominal pain—Procarbazine—brain cancer	0.00118	0.0024	CcSEcCtD
Naltrexone—Body temperature increased—Procarbazine—brain cancer	0.00118	0.0024	CcSEcCtD
Naltrexone—Cardiac disorder—Temozolomide—brain cancer	0.00118	0.00239	CcSEcCtD
Naltrexone—Alopecia—Carmustine—brain cancer	0.00116	0.00236	CcSEcCtD
Naltrexone—Oedema—Hydroxyurea—brain cancer	0.00116	0.00234	CcSEcCtD
Naltrexone—Angiopathy—Temozolomide—brain cancer	0.00115	0.00234	CcSEcCtD
Naltrexone—Mental disorder—Carmustine—brain cancer	0.00115	0.00234	CcSEcCtD
Naltrexone—Infection—Hydroxyurea—brain cancer	0.00115	0.00233	CcSEcCtD
Naltrexone—Immune system disorder—Temozolomide—brain cancer	0.00115	0.00233	CcSEcCtD
Naltrexone—Mediastinal disorder—Temozolomide—brain cancer	0.00115	0.00232	CcSEcCtD
Naltrexone—Malnutrition—Carmustine—brain cancer	0.00115	0.00232	CcSEcCtD
Naltrexone—Chills—Temozolomide—brain cancer	0.00114	0.00231	CcSEcCtD
Naltrexone—Pneumonia—Etoposide—brain cancer	0.00114	0.00231	CcSEcCtD
Naltrexone—ABCB1—telencephalon—brain cancer	0.00114	0.0107	CbGeAlD
Naltrexone—Nervous system disorder—Hydroxyurea—brain cancer	0.00114	0.0023	CcSEcCtD
Naltrexone—Infestation NOS—Etoposide—brain cancer	0.00113	0.0023	CcSEcCtD
Naltrexone—Infestation—Etoposide—brain cancer	0.00113	0.0023	CcSEcCtD
Naltrexone—Alopecia—Temozolomide—brain cancer	0.00112	0.00228	CcSEcCtD
Naltrexone—Skin disorder—Hydroxyurea—brain cancer	0.00112	0.00228	CcSEcCtD
Naltrexone—Acute coronary syndrome—Etoposide—brain cancer	0.00112	0.00227	CcSEcCtD
Naltrexone—Mental disorder—Temozolomide—brain cancer	0.00112	0.00226	CcSEcCtD
Naltrexone—Myocardial infarction—Etoposide—brain cancer	0.00111	0.00225	CcSEcCtD
Naltrexone—Back pain—Carmustine—brain cancer	0.00111	0.00225	CcSEcCtD
Naltrexone—Malnutrition—Temozolomide—brain cancer	0.00111	0.00224	CcSEcCtD
Naltrexone—Anorexia—Hydroxyurea—brain cancer	0.0011	0.00224	CcSEcCtD
Naltrexone—Hypersensitivity—Procarbazine—brain cancer	0.0011	0.00223	CcSEcCtD
Naltrexone—Dysgeusia—Temozolomide—brain cancer	0.00109	0.0022	CcSEcCtD
Naltrexone—Vision blurred—Carmustine—brain cancer	0.00108	0.00219	CcSEcCtD
Naltrexone—Tremor—Carmustine—brain cancer	0.00107	0.00218	CcSEcCtD
Naltrexone—Asthenia—Procarbazine—brain cancer	0.00107	0.00217	CcSEcCtD
Naltrexone—Hepatobiliary disease—Etoposide—brain cancer	0.00107	0.00217	CcSEcCtD
Naltrexone—Back pain—Temozolomide—brain cancer	0.00107	0.00217	CcSEcCtD
Naltrexone—Pruritus—Procarbazine—brain cancer	0.00106	0.00214	CcSEcCtD
Naltrexone—Agitation—Carmustine—brain cancer	0.00105	0.00213	CcSEcCtD
Naltrexone—Vision blurred—Temozolomide—brain cancer	0.00104	0.00212	CcSEcCtD
Naltrexone—Tremor—Temozolomide—brain cancer	0.00104	0.0021	CcSEcCtD
Naltrexone—Dyspnoea—Hydroxyurea—brain cancer	0.00103	0.00209	CcSEcCtD
Naltrexone—Somnolence—Hydroxyurea—brain cancer	0.00103	0.00208	CcSEcCtD
Naltrexone—Ill-defined disorder—Temozolomide—brain cancer	0.00103	0.00208	CcSEcCtD
Naltrexone—Diarrhoea—Procarbazine—brain cancer	0.00102	0.00207	CcSEcCtD
Naltrexone—Agitation—Temozolomide—brain cancer	0.00102	0.00206	CcSEcCtD
Naltrexone—Angioedema—Temozolomide—brain cancer	0.00101	0.00205	CcSEcCtD
Naltrexone—Decreased appetite—Hydroxyurea—brain cancer	0.00101	0.00204	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000999	0.00202	CcSEcCtD
Naltrexone—Malaise—Temozolomide—brain cancer	0.000999	0.00202	CcSEcCtD
Naltrexone—Fatigue—Hydroxyurea—brain cancer	0.000998	0.00202	CcSEcCtD
Naltrexone—Convulsion—Carmustine—brain cancer	0.000994	0.00201	CcSEcCtD
Naltrexone—Hypertension—Carmustine—brain cancer	0.00099	0.00201	CcSEcCtD
Naltrexone—Pain—Hydroxyurea—brain cancer	0.00099	0.00201	CcSEcCtD
Naltrexone—Constipation—Hydroxyurea—brain cancer	0.00099	0.00201	CcSEcCtD
Naltrexone—Dizziness—Procarbazine—brain cancer	0.000989	0.002	CcSEcCtD
Naltrexone—Palpitations—Temozolomide—brain cancer	0.000979	0.00198	CcSEcCtD
Naltrexone—Chest pain—Carmustine—brain cancer	0.000976	0.00198	CcSEcCtD
Naltrexone—Myalgia—Carmustine—brain cancer	0.000976	0.00198	CcSEcCtD
Naltrexone—Anxiety—Carmustine—brain cancer	0.000973	0.00197	CcSEcCtD
Naltrexone—Cough—Temozolomide—brain cancer	0.000967	0.00196	CcSEcCtD
Naltrexone—Convulsion—Temozolomide—brain cancer	0.00096	0.00194	CcSEcCtD
Naltrexone—Hypertension—Temozolomide—brain cancer	0.000957	0.00194	CcSEcCtD
Naltrexone—Feeling abnormal—Hydroxyurea—brain cancer	0.000954	0.00193	CcSEcCtD
Naltrexone—Eye disorder—Etoposide—brain cancer	0.000952	0.00193	CcSEcCtD
Naltrexone—Vomiting—Procarbazine—brain cancer	0.000951	0.00193	CcSEcCtD
Naltrexone—ABCB1—gonad—brain cancer	0.000948	0.00893	CbGeAlD
Naltrexone—Cardiac disorder—Etoposide—brain cancer	0.000945	0.00191	CcSEcCtD
Naltrexone—Confusional state—Carmustine—brain cancer	0.000944	0.00191	CcSEcCtD
Naltrexone—Myalgia—Temozolomide—brain cancer	0.000943	0.00191	CcSEcCtD
Naltrexone—Arthralgia—Temozolomide—brain cancer	0.000943	0.00191	CcSEcCtD
Naltrexone—Rash—Procarbazine—brain cancer	0.000943	0.00191	CcSEcCtD
Naltrexone—Dermatitis—Procarbazine—brain cancer	0.000942	0.00191	CcSEcCtD
Naltrexone—Anxiety—Temozolomide—brain cancer	0.00094	0.0019	CcSEcCtD
Naltrexone—Headache—Procarbazine—brain cancer	0.000937	0.0019	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000937	0.0019	CcSEcCtD
Naltrexone—Oedema—Carmustine—brain cancer	0.000936	0.0019	CcSEcCtD
Naltrexone—Discomfort—Temozolomide—brain cancer	0.000932	0.00189	CcSEcCtD
Naltrexone—Infection—Carmustine—brain cancer	0.00093	0.00188	CcSEcCtD
Naltrexone—ABCB1—pituitary gland—brain cancer	0.000925	0.00871	CbGeAlD
Naltrexone—Angiopathy—Etoposide—brain cancer	0.000924	0.00187	CcSEcCtD
Naltrexone—Dry mouth—Temozolomide—brain cancer	0.000923	0.00187	CcSEcCtD
Naltrexone—Immune system disorder—Etoposide—brain cancer	0.00092	0.00186	CcSEcCtD
Naltrexone—Mediastinal disorder—Etoposide—brain cancer	0.000918	0.00186	CcSEcCtD
Naltrexone—Body temperature increased—Hydroxyurea—brain cancer	0.000915	0.00185	CcSEcCtD
Naltrexone—Chills—Etoposide—brain cancer	0.000914	0.00185	CcSEcCtD
Naltrexone—Tachycardia—Carmustine—brain cancer	0.000913	0.00185	CcSEcCtD
Naltrexone—Confusional state—Temozolomide—brain cancer	0.000912	0.00185	CcSEcCtD
Naltrexone—Oedema—Temozolomide—brain cancer	0.000904	0.00183	CcSEcCtD
Naltrexone—Anaphylactic shock—Temozolomide—brain cancer	0.000904	0.00183	CcSEcCtD
Naltrexone—Alopecia—Etoposide—brain cancer	0.0009	0.00182	CcSEcCtD
Naltrexone—Infection—Temozolomide—brain cancer	0.000899	0.00182	CcSEcCtD
Naltrexone—ABCB1—medulla oblongata—brain cancer	0.000893	0.00841	CbGeAlD
Naltrexone—Anorexia—Carmustine—brain cancer	0.000892	0.00181	CcSEcCtD
Naltrexone—Nausea—Procarbazine—brain cancer	0.000889	0.0018	CcSEcCtD
Naltrexone—Nervous system disorder—Temozolomide—brain cancer	0.000887	0.0018	CcSEcCtD
Naltrexone—Skin disorder—Temozolomide—brain cancer	0.000878	0.00178	CcSEcCtD
Naltrexone—Hyperhidrosis—Temozolomide—brain cancer	0.000874	0.00177	CcSEcCtD
Naltrexone—Dysgeusia—Etoposide—brain cancer	0.000868	0.00176	CcSEcCtD
Naltrexone—Anorexia—Temozolomide—brain cancer	0.000862	0.00175	CcSEcCtD
Naltrexone—Back pain—Etoposide—brain cancer	0.000858	0.00174	CcSEcCtD
Naltrexone—Hypersensitivity—Hydroxyurea—brain cancer	0.000853	0.00173	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Carmustine—brain cancer	0.000853	0.00173	CcSEcCtD
Naltrexone—Muscle spasms—Etoposide—brain cancer	0.000853	0.00173	CcSEcCtD
Naltrexone—Insomnia—Carmustine—brain cancer	0.000846	0.00171	CcSEcCtD
Naltrexone—Paraesthesia—Carmustine—brain cancer	0.00084	0.0017	CcSEcCtD
Naltrexone—Dyspnoea—Carmustine—brain cancer	0.000834	0.00169	CcSEcCtD
Naltrexone—Somnolence—Carmustine—brain cancer	0.000832	0.00169	CcSEcCtD
Naltrexone—Asthenia—Hydroxyurea—brain cancer	0.000831	0.00168	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000824	0.00167	CcSEcCtD
Naltrexone—Ill-defined disorder—Etoposide—brain cancer	0.000823	0.00167	CcSEcCtD
Naltrexone—Insomnia—Temozolomide—brain cancer	0.000818	0.00166	CcSEcCtD
Naltrexone—ABCB1—midbrain—brain cancer	0.000816	0.00768	CbGeAlD
Naltrexone—Decreased appetite—Carmustine—brain cancer	0.000814	0.00165	CcSEcCtD
Naltrexone—Paraesthesia—Temozolomide—brain cancer	0.000812	0.00164	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Carmustine—brain cancer	0.000808	0.00164	CcSEcCtD
Naltrexone—Dyspnoea—Temozolomide—brain cancer	0.000806	0.00163	CcSEcCtD
Naltrexone—Somnolence—Temozolomide—brain cancer	0.000804	0.00163	CcSEcCtD
Naltrexone—Pain—Carmustine—brain cancer	0.0008	0.00162	CcSEcCtD
Naltrexone—Constipation—Carmustine—brain cancer	0.0008	0.00162	CcSEcCtD
Naltrexone—Malaise—Etoposide—brain cancer	0.0008	0.00162	CcSEcCtD
Naltrexone—ABCB1—spinal cord—brain cancer	0.000796	0.0075	CbGeAlD
Naltrexone—Diarrhoea—Hydroxyurea—brain cancer	0.000792	0.0016	CcSEcCtD
Naltrexone—Decreased appetite—Temozolomide—brain cancer	0.000786	0.00159	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Temozolomide—brain cancer	0.000781	0.00158	CcSEcCtD
Naltrexone—Fatigue—Temozolomide—brain cancer	0.00078	0.00158	CcSEcCtD
Naltrexone—Loss of consciousness—Etoposide—brain cancer	0.000779	0.00158	CcSEcCtD
Naltrexone—Cough—Etoposide—brain cancer	0.000774	0.00157	CcSEcCtD
Naltrexone—Pain—Temozolomide—brain cancer	0.000773	0.00157	CcSEcCtD
Naltrexone—Constipation—Temozolomide—brain cancer	0.000773	0.00157	CcSEcCtD
Naltrexone—Feeling abnormal—Carmustine—brain cancer	0.000771	0.00156	CcSEcCtD
Naltrexone—Convulsion—Etoposide—brain cancer	0.000768	0.00156	CcSEcCtD
Naltrexone—Hypertension—Etoposide—brain cancer	0.000766	0.00155	CcSEcCtD
Naltrexone—Dizziness—Hydroxyurea—brain cancer	0.000766	0.00155	CcSEcCtD
Naltrexone—Gastrointestinal pain—Carmustine—brain cancer	0.000765	0.00155	CcSEcCtD
Naltrexone—Chest pain—Etoposide—brain cancer	0.000755	0.00153	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00075	0.00152	CcSEcCtD
Naltrexone—Discomfort—Etoposide—brain cancer	0.000746	0.00151	CcSEcCtD
Naltrexone—Feeling abnormal—Temozolomide—brain cancer	0.000745	0.00151	CcSEcCtD
Naltrexone—Abdominal pain—Carmustine—brain cancer	0.00074	0.0015	CcSEcCtD
Naltrexone—Body temperature increased—Carmustine—brain cancer	0.00074	0.0015	CcSEcCtD
Naltrexone—Gastrointestinal pain—Temozolomide—brain cancer	0.00074	0.0015	CcSEcCtD
Naltrexone—Vomiting—Hydroxyurea—brain cancer	0.000736	0.00149	CcSEcCtD
Naltrexone—Rash—Hydroxyurea—brain cancer	0.00073	0.00148	CcSEcCtD
Naltrexone—Confusional state—Etoposide—brain cancer	0.00073	0.00148	CcSEcCtD
Naltrexone—Dermatitis—Hydroxyurea—brain cancer	0.000729	0.00148	CcSEcCtD
Naltrexone—Headache—Hydroxyurea—brain cancer	0.000725	0.00147	CcSEcCtD
Naltrexone—Anaphylactic shock—Etoposide—brain cancer	0.000724	0.00147	CcSEcCtD
Naltrexone—Infection—Etoposide—brain cancer	0.000719	0.00146	CcSEcCtD
Naltrexone—Urticaria—Temozolomide—brain cancer	0.000718	0.00146	CcSEcCtD
Naltrexone—ABCB1—endocrine gland—brain cancer	0.000716	0.00675	CbGeAlD
Naltrexone—Body temperature increased—Temozolomide—brain cancer	0.000715	0.00145	CcSEcCtD
Naltrexone—Abdominal pain—Temozolomide—brain cancer	0.000715	0.00145	CcSEcCtD
Naltrexone—ABCB1—head—brain cancer	0.000707	0.00666	CbGeAlD
Naltrexone—Tachycardia—Etoposide—brain cancer	0.000706	0.00143	CcSEcCtD
Naltrexone—Skin disorder—Etoposide—brain cancer	0.000703	0.00142	CcSEcCtD
Naltrexone—Hyperhidrosis—Etoposide—brain cancer	0.0007	0.00142	CcSEcCtD
Naltrexone—Anorexia—Etoposide—brain cancer	0.00069	0.0014	CcSEcCtD
Naltrexone—Hypersensitivity—Carmustine—brain cancer	0.00069	0.0014	CcSEcCtD
Naltrexone—Nausea—Hydroxyurea—brain cancer	0.000688	0.00139	CcSEcCtD
Naltrexone—Asthenia—Carmustine—brain cancer	0.000671	0.00136	CcSEcCtD
Naltrexone—Hypersensitivity—Temozolomide—brain cancer	0.000666	0.00135	CcSEcCtD
Naltrexone—Paraesthesia—Etoposide—brain cancer	0.00065	0.00132	CcSEcCtD
Naltrexone—Asthenia—Temozolomide—brain cancer	0.000649	0.00131	CcSEcCtD
Naltrexone—ABCB1—central nervous system—brain cancer	0.000646	0.00608	CbGeAlD
Naltrexone—Dyspnoea—Etoposide—brain cancer	0.000645	0.00131	CcSEcCtD
Naltrexone—Somnolence—Etoposide—brain cancer	0.000643	0.0013	CcSEcCtD
Naltrexone—Diarrhoea—Carmustine—brain cancer	0.00064	0.0013	CcSEcCtD
Naltrexone—Pruritus—Temozolomide—brain cancer	0.00064	0.0013	CcSEcCtD
Naltrexone—ABCB1—cerebellum—brain cancer	0.000631	0.00594	CbGeAlD
Naltrexone—Decreased appetite—Etoposide—brain cancer	0.000629	0.00127	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Etoposide—brain cancer	0.000625	0.00127	CcSEcCtD
Naltrexone—Fatigue—Etoposide—brain cancer	0.000624	0.00126	CcSEcCtD
Naltrexone—Dizziness—Carmustine—brain cancer	0.000619	0.00125	CcSEcCtD
Naltrexone—Pain—Etoposide—brain cancer	0.000619	0.00125	CcSEcCtD
Naltrexone—Constipation—Etoposide—brain cancer	0.000619	0.00125	CcSEcCtD
Naltrexone—Diarrhoea—Temozolomide—brain cancer	0.000619	0.00125	CcSEcCtD
Naltrexone—Dizziness—Temozolomide—brain cancer	0.000598	0.00121	CcSEcCtD
Naltrexone—Feeling abnormal—Etoposide—brain cancer	0.000596	0.00121	CcSEcCtD
Naltrexone—Vomiting—Carmustine—brain cancer	0.000595	0.00121	CcSEcCtD
Naltrexone—Gastrointestinal pain—Etoposide—brain cancer	0.000592	0.0012	CcSEcCtD
Naltrexone—Rash—Carmustine—brain cancer	0.00059	0.0012	CcSEcCtD
Naltrexone—Dermatitis—Carmustine—brain cancer	0.00059	0.00119	CcSEcCtD
Naltrexone—Headache—Carmustine—brain cancer	0.000586	0.00119	CcSEcCtD
Naltrexone—Vomiting—Temozolomide—brain cancer	0.000575	0.00116	CcSEcCtD
Naltrexone—Urticaria—Etoposide—brain cancer	0.000575	0.00116	CcSEcCtD
Naltrexone—Abdominal pain—Etoposide—brain cancer	0.000572	0.00116	CcSEcCtD
Naltrexone—Body temperature increased—Etoposide—brain cancer	0.000572	0.00116	CcSEcCtD
Naltrexone—Rash—Temozolomide—brain cancer	0.00057	0.00116	CcSEcCtD
Naltrexone—Dermatitis—Temozolomide—brain cancer	0.00057	0.00115	CcSEcCtD
Naltrexone—Headache—Temozolomide—brain cancer	0.000567	0.00115	CcSEcCtD
Naltrexone—Nausea—Carmustine—brain cancer	0.000556	0.00113	CcSEcCtD
Naltrexone—Nausea—Temozolomide—brain cancer	0.000537	0.00109	CcSEcCtD
Naltrexone—Hypersensitivity—Etoposide—brain cancer	0.000533	0.00108	CcSEcCtD
Naltrexone—Asthenia—Etoposide—brain cancer	0.000519	0.00105	CcSEcCtD
Naltrexone—ABCB1—brain—brain cancer	0.000513	0.00483	CbGeAlD
Naltrexone—Pruritus—Etoposide—brain cancer	0.000512	0.00104	CcSEcCtD
Naltrexone—Diarrhoea—Etoposide—brain cancer	0.000495	0.001	CcSEcCtD
Naltrexone—Dizziness—Etoposide—brain cancer	0.000479	0.000969	CcSEcCtD
Naltrexone—Vomiting—Etoposide—brain cancer	0.00046	0.000932	CcSEcCtD
Naltrexone—Rash—Etoposide—brain cancer	0.000456	0.000924	CcSEcCtD
Naltrexone—Dermatitis—Etoposide—brain cancer	0.000456	0.000923	CcSEcCtD
Naltrexone—Headache—Etoposide—brain cancer	0.000453	0.000918	CcSEcCtD
Naltrexone—Nausea—Etoposide—brain cancer	0.00043	0.000871	CcSEcCtD
